The Prostate. Supplement最新文献_第9页

Complete androgen blockade in prostate cancer: an overview of randomized trials. 完全雄激素阻断前列腺癌:随机试验综述。

The Prostate. Supplement Pub Date : 1992-01-01 DOI: 10.1002/pros.2990210517

O Dalesio

引用次数: 8

DNA content/ploidy as prognostic factors in prostate cancer. DNA含量/倍体作为前列腺癌的预后因素。

The Prostate. Supplement Pub Date : 1992-01-01 DOI: 10.1002/pros.2990210519

M M Lieber

{"title":"DNA content/ploidy as prognostic factors in prostate cancer.","authors":"M M Lieber","doi":"10.1002/pros.2990210519","DOIUrl":"https://doi.org/10.1002/pros.2990210519","url":null,"abstract":"Modern electronic analytic instruments and computers make determination of DNA content/ploidy from individual tumor cells an efficient, accurate, and economical process. Both flow-cytometric, singlecell DNA content measurements and static image cytometry, using histologic sections stained by the Feulgen process are commonly used methodologies. DNA content/ploidy can now be reliably measured by flow cytometry, either from fresh tissues or, using theHedley methodology, from formalin-fixed, paraffin-embedded tissues. Cytologic needle aspirates of the prostate and prostate tissue specimens obtained by radical prostatectomy, transurethral resection, or needle biopsy can be studied effectively by either flow or static image cytometry. In certain countries, particularly the USA, DNA content/ploidy is a routinely available laboratory test that can be obtained at about the same price as standard histologic analysis; there is every reason to believe that DNA content/ploidy measurement of human prostate cancer is a more objective, accurate, and reproducible method of grading such tumors than is human microscopic grading, particularly for intermediate grade (Gleason 5-7) tumors.","PeriodicalId":77436,"journal":{"name":"The Prostate. Supplement","volume":"4 ","pages":"119-24"},"PeriodicalIF":0.0,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/pros.2990210519","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12741557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

The TNM classification of prostate cancer. 前列腺癌的TNM分类。

The Prostate. Supplement Pub Date : 1992-01-01 DOI: 10.1002/pros.2990210521

F H Schröder, P Hermanek, L Denis, W R Fair, M K Gospodarowicz, M Pavone-Macaluso

引用次数: 460

Preliminary results of three-dimensional reconstruction of previously imaged prostates. 先前成像前列腺三维重建的初步结果。

The Prostate. Supplement Pub Date : 1992-01-01 DOI: 10.1002/pros.2990210506

I A Sesterhenn, F K Mostofi, R R Mattrey, J P Sands, C J Davis, W F McCarthy

引用次数: 9

Magnetic resonance spectroscopy in prostate disease: diagnostic possibilities and future developments. 磁共振波谱在前列腺疾病:诊断的可能性和未来的发展。

The Prostate. Supplement Pub Date : 1992-01-01 DOI: 10.1002/pros.2990210507

P Narayan, J Kurhanewicz

引用次数: 35

The management of bladder outlet obstruction due to prostate cancer, untreated and after endocrine treatment. 前列腺癌所致膀胱出口梗阻，未经治疗及经内分泌治疗后的处理。

The Prostate. Supplement Pub Date : 1992-01-01 DOI: 10.1002/pros.2990210525

J E Montie

引用次数: 5

To screen or not to screen? 筛选还是不筛选?

The Prostate. Supplement Pub Date : 1992-01-01 DOI: 10.1002/pros.2990210510

L J Denis

{"title":"To screen or not to screen?","authors":"L J Denis","doi":"10.1002/pros.2990210510","DOIUrl":"https://doi.org/10.1002/pros.2990210510","url":null,"abstract":"<p><p>This paper aims to present a case for screening for prostate cancer, though medical committees from many countries have recently decided against it. It is clear that prostate cancer fails many of the criteria for an effective screening program. There is certainly no single test that can be used reliably to detect prostate cancer. All the available tests have advantages and disadvantages. The sensitivities of the three widely used screening tests--digital rectal examination (DRE), prostate specific antigen (PSA), and transrectal ultrasound (TRUS)--vary from 50% to 85% in a number of studies, but the positive predictive value fluctuates around 30%. The use of all three tests must improve the detection rate. The European Cancer Programme is funding a pilot study in Antwerp and Rotterdam on screening for prostatic diseases. In Rotterdam, a pre-screen PSA is performed and then patients are randomized to no screening or DRE with TRUS. The Antwerp section of the study includes screening for benign prostatic hyperplasia and employs a questionnaire on urinary symptoms as a pre-screen test. Patients are then randomized to controls or DRE with TRUS and, if results are suspicious, PSA measurement. It will be about 8 years before it becomes clear whether there is a resulting drop in mortality from prostate cancer.</p>","PeriodicalId":77436,"journal":{"name":"The Prostate. Supplement","volume":"4 ","pages":"63-70"},"PeriodicalIF":0.0,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/pros.2990210510","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12742207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 8

Indications and techniques of prostate biopsies. 前列腺活检的适应症和技术。

The Prostate. Supplement Pub Date : 1992-01-01 DOI: 10.1002/pros.2990210518

L Andersson

引用次数: 0

What is 'progression' in prostate cancer? 什么是前列腺癌的“进展”?

The Prostate. Supplement Pub Date : 1992-01-01 DOI: 10.1002/pros.2990210522

D W Newling

引用次数: 17

Casodex: a pure non-steroidal anti-androgen used as monotherapy in advanced prostate cancer. Casodex:一种纯非甾体抗雄激素，用于晚期前列腺癌的单药治疗。

The Prostate. Supplement Pub Date : 1992-01-01 DOI: 10.1002/pros.2990210515

C J Tyrrell

引用次数: 38